Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 15, 2010

3D Movie Warnings omit those with Neurological Conditions

  • Misc. MS Related
    /
  • Symptoms
    /
by Stuart ( as an opinion – not the part written by Stuart, rather my opinion of the 3D warning)…
Misc. MS Related

April 14, 2010

Avonex Abstracts

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Pregnancy Outcomes from AVONEX (interferon beta-1a) Pregnancy Exposure Registry:http://www.abstracts2view.com/aan/view.php?nu=AAN10L_P04.186&terms= Utilization and Safety of Intramuscular Interferon Beta-1a in the Postmarketing Setting:http://www.abstracts2view.com/aan/view.php?nu=AAN10L_P06.146&terms=…
MS Drug Therapies

April 14, 2010

New Treatment Helps Control Involuntary Crying And Laughing Common In MS, ALS Patients

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Symptoms
    /
April 14, 2010 Pseudobulbar affect (PBA) is a neurologic condition of involuntary, sudden and frequent episodes of laughing or crying…
MS Research Study and Reports

April 14, 2010

Biogen Seeks Test for Brain Disease Linked to MS Drug

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
Biogen Seeks Test for Brain Disease Linked to MS Drug (Update2) Bloomberg.com By Elizabeth Lopatto April 9 (Bloomberg) — Biogen…
MS Drug Therapies

April 13, 2010

Stem cell research forges ahead in Ecuador

  • Stem Cell Related
    /
South American destinations such as Ecuador are joining stem cell research communities around the world in seeking stem cell therapies…
Stem Cell Related

April 13, 2010

MS Patients Need Backup when Stopping Natalizumab (Tysabri)

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
Information provided by Karen M in Miami. By Ed Susman, Contributing Writer, MedPage TodayPublished: April 12, 2010Reviewed by Ari Green,…
MS Research Study and Reports

April 13, 2010

Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Arch Neurol. 2010;67(4):402-407. Objectives To confirm that neutralizing antibodies (NAb) to interferon beta can persist after therapy withdrawal and to…
MS Research Study and Reports

April 13, 2010

Teva Announces Copaxone(R) Reaches One Million Patient Years of Experience in the Treatment of Multiple Sclerosis

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Approved in 1996, Copaxone(R) is the global market leader in the treatment of relapsing-remitting multiple sclerosis (RRMS) JERUSALEM, Apr 12,…
MS Drug Therapies

April 13, 2010

Gilenia (an Oral MS therapy) Reduces Relapse Rates

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Published: 13-Apr-2010 * Data of Novartis Pharma Freedoms study presented at the American Academy of Neurology (AAN) annual meeting showed…
MS Drug Therapies

April 11, 2010

Impact of Warm Compresses on Local Injection-Site Reactions with Self-Administered Glatiramer Acetate

  • Additional MS resource sites
    /
  • For the Benefit of the Patient
    /
  • Multiple Sclerosis
    /
Source: Journal of Neuroscience NursingBY: Jolly, Helen; Simpson, Kellie; Bishop, Barbara; Hunter, Heli; Newell, Cassie; Denney, Douglas; Oleen-Burkey, MerriKay Patients…
Additional MS resource sites

Categories

Latest Blog Posts